Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is included on our list of stocks under $1 that will explode. On December 18, 2025, ...

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Werewolf Therapeutics, Inc. (HOWL) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.53 per share a year ago. These ...

Matthew Galea is a features writer for CBR. He spends his day as a high school English teacher, and every other minute watching, thinking and writing about movies and television. From Lon Chaney Jr.'s ...

HOWL reported interim data in November from its phase 1/1b trial of WTX-124 in solid tumors. There are signs of antitumor activity at the 12 mg dose of WTX-124, with two unconfirmed partial responses ...

There are tons and tons of scary movies about vampires, demons and ghosts—but werewolf movies tend to only come around once in a blue moon (in other words, far less frequently than the full moons that ...

Director Luke Evnin reported selling shares of Werewolf Therapeutics Inc (NASDAQ:HOWL) between December 2nd and December 4th, 2025. The sales, executed under a prearranged 10b5-1 trading plan, totaled ...

MPM Asset Management LLC and related entities, all of whom are 10% owners of Werewolf Therapeutics, Inc. (NASDAQ:HOWL), sold a total of 179551 shares of common stock for approximately $179,551. The ...

Funny dog Maymo is pranked by a werewolf. When there is a werewolf sighting in this cute beagle's living room, watch how the dog reacts to this unwelcome monster.